Short Half-Life: Tc-99m has a relatively short half-life of approximately six hours. This means that it decays quickly, and its radioactivity decreases over time. As a result, Tc-99m must be produced and used within a short period, which can be logistically challenging.
Limited Availability: The production of Tc-99m is dependent on the availability of molybdenum-99 (Mo-99), which is its parent isotope. Mo-99 is produced in specialized nuclear reactors, and any disruptions in its supply can affect the availability of Tc-99m. This can lead to shortages and impact medical imaging procedures that rely on Tc-99m.
Radiation Exposure: Tc-99m emits gamma radiation during its decay. While the radiation dose is generally low, it can still contribute to the cumulative radiation exposure of patients and medical professionals involved in its administration and handling. Radiation safety measures and precautions are necessary to minimize exposure.
Cost: The production and distribution of Tc-99m involve specialized facilities, equipment, and logistics, which can contribute to its cost. The short half-life and limited availability can also affect its cost-effectiveness, particularly in remote or resource-limited areas.
Potential Allergic Reactions: In rare cases, some individuals may experience allergic reactions to Tc-99m or the compounds used in its preparation. These reactions can range from mild to severe and should be considered during patient screening and administration.
It's important for medical professionals to weigh these disadvantages against the benefits and consider alternative imaging options when appropriate to ensure the safe and effective use of Tc-99m in nuclear medicine procedures.
